KR100721983B1 - Method of Extracting Finitol from Non-Repair and Functional Food Using Extract - Google Patents
Method of Extracting Finitol from Non-Repair and Functional Food Using Extract Download PDFInfo
- Publication number
- KR100721983B1 KR100721983B1 KR1020050071952A KR20050071952A KR100721983B1 KR 100721983 B1 KR100721983 B1 KR 100721983B1 KR 1020050071952 A KR1020050071952 A KR 1020050071952A KR 20050071952 A KR20050071952 A KR 20050071952A KR 100721983 B1 KR100721983 B1 KR 100721983B1
- Authority
- KR
- South Korea
- Prior art keywords
- repair
- finitol
- extract
- extracting
- supernatant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 27
- 239000000284 extract Substances 0.000 title claims abstract description 23
- 235000013376 functional food Nutrition 0.000 title abstract description 7
- 230000008439 repair process Effects 0.000 claims abstract description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000006228 supernatant Substances 0.000 claims abstract description 14
- 238000005119 centrifugation Methods 0.000 claims abstract description 9
- 238000001556 precipitation Methods 0.000 claims abstract description 9
- 238000000227 grinding Methods 0.000 claims abstract description 6
- 238000000926 separation method Methods 0.000 claims abstract description 6
- 238000001291 vacuum drying Methods 0.000 claims abstract description 5
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000003456 ion exchange resin Substances 0.000 claims abstract description 4
- 229920003303 ion-exchange polymer Polymers 0.000 claims abstract description 4
- 239000007787 solid Substances 0.000 claims abstract description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 23
- 210000004369 blood Anatomy 0.000 abstract description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 15
- 239000008103 glucose Substances 0.000 abstract description 15
- DSCFFEYYQKSRSV-UHFFFAOYSA-N 1L-O1-methyl-muco-inositol Natural products COC1C(O)C(O)C(O)C(O)C1O DSCFFEYYQKSRSV-UHFFFAOYSA-N 0.000 abstract description 14
- VJXUJFAZXQOXMJ-UHFFFAOYSA-N D-1-O-Methyl-muco-inositol Natural products CC12C(OC)(C)OC(C)(C)C2CC(=O)C(C23OC2C(=O)O2)(C)C1CCC3(C)C2C=1C=COC=1 VJXUJFAZXQOXMJ-UHFFFAOYSA-N 0.000 abstract description 14
- DSCFFEYYQKSRSV-KLJZZCKASA-N D-pinitol Chemical compound CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O DSCFFEYYQKSRSV-KLJZZCKASA-N 0.000 abstract description 14
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 238000001035 drying Methods 0.000 abstract description 4
- 239000007788 liquid Substances 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 244000068988 Glycine max Species 0.000 description 6
- 235000010469 Glycine max Nutrition 0.000 description 6
- 230000002641 glycemic effect Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- CDAISMWEOUEBRE-LKPKBOIGSA-N 1D-chiro-inositol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O CDAISMWEOUEBRE-LKPKBOIGSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- 244000297531 Lespedeza cuneata Species 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 240000008299 Pinus lambertiana Species 0.000 description 2
- 235000008595 Pinus lambertiana Nutrition 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000001030 gas--liquid chromatography Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009933 reproductive health Effects 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 241000219475 Bougainvillea Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 244000110556 Cyclopia subternata Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 244000275012 Sesbania cannabina Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- -1 finitol Natural products 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000002608 insulinlike Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003129 oil well Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/51—Concentration
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
비수리(Lespedeza cuneata)에서 혈당조절 물질인 피니톨을 추출하여 당뇨병에 유용한 천연 피니톨을 사용하여 혈당조절 기능성식품을 제조하는 방법에 관한 것으로서, 비수리에서 피니톨을 추출하는 방법에 있어, 상기 비수리를 에탄올에 첨가하고 호모게나이저로 분쇄하는 첨가분쇄단계, 분쇄된 비수리를 알콜에 정치시키는 침전단계, 침전단계에서 회수된 상등액을 원심분리하는 원심분리단계, 원심분리단계에서 회수된 상등액을 감압건조하는 감압건조단계, 감압건조단계에서 얻어진 고형분을 분리하는 분리단계, 분리된 상등액을 이온교환수지필터를 통과 시킨 후 그 추출물을 동결건조하는 단계를 마련한다.The present invention relates to a method for manufacturing a blood glucose control functional food using natural pinitol, which is useful for diabetes, by extracting pinitol, a blood sugar control substance, from a non-repair, in which a non-repair is added to ethanol. Additive grinding step of grinding with a homogenizer, precipitation step of leaving the crushed non-repair in alcohol, centrifugation step of centrifugation of the supernatant recovered from the precipitation step, and drying under reduced pressure to dry the supernatant liquid recovered from the centrifugation step under reduced pressure. In addition, a separation step of separating the solids obtained in the vacuum drying step, and passing the separated supernatant through an ion exchange resin filter to prepare a step of lyophilizing the extract.
또한, 비수리는 특별히 경제작물이 경종(耕種)되지 않는 야산이나 유휴지를 이용하여 전초를 생산할 수 있으므로 토지이용을 높일 뿐만 아니라 재배하는데도 많은 비용이 들지 않으므로 경제적인 효과도 얻을 수 있다.In addition, the non-nuri can produce the outpost using the mountain or idle land, where the economic crops are not particularly seeded, so as not only to increase land use but also cost much to cultivate, economic effects can be obtained.
비수리, 피니톨, 혈당, 당뇨병 Non-Repair, Finitol, Blood Sugar, Diabetes
Description
도 1은 본 발명에 따라 비수리에서 피니톨을 추출방법을 나타낸 순서도.1 is a flow chart showing a method for extracting finitol from non-repair according to the present invention.
본 발명은 비수리에서 피니톨을 추출하는 방법과 추출물을 이용한 기능성식품에 관한 것으로서, 특히 비수리(Lespedeza cuneata)에서 혈당조절 물질인 피니톨을 추출하여 당뇨병에 유용한 천연 피니톨을 사용하여 혈당조절 기능성식품을 제조하는 방법에 관한 것이다.The present invention relates to a method for extracting pinitol from non-repair and a functional food using the extract, in particular, to extract a blood glucose control substance finitol from non-repair (Lespedeza cuneata) to produce a blood glucose control functional food using natural finitol useful for diabetes It is about a method.
비수리(Lespedeza cuneata)는 밤에 빗장을 열어주는 약초라는 뜻이며, 이것을 먹으면 천리 밖에서도 빛이 난다고 하여 천리광(千里光)이라고 한다. 또한 큰힘을 나게한다 하여 대력왕(大力王)이라고 하며, 뱀을 쫓는다고 하여 사퇴초(蛇退草)라고 한다. 비수리는 여러가지 남성질병, 양기부족, 조루, 유정, 음위증 등을 치료하는데 뛰어난 효력이 있으며, 특히 신장기능이 허약한 노인들의 양기부족에 탁월한 효과가 있다. 비수리의 잎, 뿌리, 줄기에는 플라보노이드, 피니톨, 페놀, 탄닌, 시토스테롤 등들어 있는데, 이들 성분은 염증을 없애고 가래를 삭이며, 황색포도상구균, 폐렴상구균, 연쇄상구균, 카타르구균 등을 죽이거나 억제한다.(김태정, 한국자원식물, 서울대학교 출판부, 1996; 최진규, 약이되는 우리 풀, 꽃, 나무, 한문화, 2001)Beesuri (Lespedeza cuneata) means a herb that opens the bar at night, and when it is eaten, it is said to shine around outside the sky. It is also called the Great King (大力 王) because of the great power, and because it is chasing snakes. Non-auri has excellent effects in treating various male diseases, lack of nourishment, premature ejaculation, oil well, vulgaris, etc., especially in elderly people with weak kidney function. The leaves, roots, and stems of the rhinoceros contain flavonoids, finitol, phenol, tannin, and cytosterol, which remove inflammation and sputum, kill or inhibit staphylococcus aureus, pneumococci, streptococci, and catarrhals. (Kim Tae-Jung, Korea Plant Resources, Seoul National University Press, 1996; Jin-Kyu Choi, Our Herb, Flower, Tree, Korean Culture, 2001)
일반적으로 당뇨환자에게 있어 혈당조절은 약물치료법, 식이요법, 운동요법이 병행되거나 단독적으로 이뤄지는 경우가 많다. 특히 지금까지 당뇨환자에게 혈당조절 유효성분으로 알려진 피니톨은 콩류나 솔잎 등에 포함되어 있는 천연혈당 강화성분으로서, 인도 서부지역에서는 전통적으로 당뇨환자에 대한 약재로서 부우겐빌리아(Bougainvillea)라는 콩과류 식물의 잎을 사용해 왔는데 과학자들의 연구 결과 그 유효성분이 피니톨(pinitol)이라는 사실이 확인하였다.In general, for diabetics, glycemic control is often performed alone or in combination with medication, diet and exercise. In particular, Finitol, which has been known as an effective glycemic control ingredient for diabetic patients, is a natural blood sugar-enhancing ingredient contained in legumes and pine needles. In western India, a legume called Bougainvillea is traditionally used as a medicine for diabetic patients. Plant leaves have been used, and scientists have found that the active ingredient is pinitol.
그리고 콩 뿐만 아니라 몬순기후 지역인 인도에서 재배되는 Dhaincha 식물의 잎 그리고 아프리카 지역의 Honeybush 등의 식물에서도 혈당조절 유효성분인 피니톨이 존재한다는 보고가 있다.In addition, there are reports that pinitol, an effective glycemic control agent, exists in the leaves of Dhaincha plants grown in India, monsoon climate, and Honeybush plants in Africa.
피니톨은 슈가파인(Pinus lambertiana Dougl)의 줄기에서 처음 알려진 d-chiro-inositol을 일컫는다. 즉, 소나무에서 추출된 포도당이 메틸에스테르결합을 갖는 당알코올의 일종이다.Finitol is the first known d-chiro-inositol in the stems of the sugar pine (Pinus lambertiana Dougl). That is, glucose extracted from pine is a kind of sugar alcohol having a methyl ester bond.
당알코올의 일종인 피니톨이 혈당조절에 유용한 성분임이 알려진 것은 영국약리학회지에 피니톨이 인슐린과 비슷한 작용을 한다는 것이 소개("Insulin-like effect of Pinitol", 2000년 제130권, 1944~1948p)되면서부터 많은 학자들에 의해 집중적으로 혈당강화효과에 대해 연구하였다.Finitol, a type of sugar alcohol, is known to be a useful ingredient for blood sugar control. The British pharmacological journal introduced the fact that pinitol acts like insulin ("Insulin-like effect of Pinitol", 2000, Vol. 130, 1944 ~ 1948p). Since then, many scholars have intensively studied the effects of glycemic fortification.
또한 혈당이 에너지원으로 사용되도록 도움을 주거나 포도당을 글리코겐으로 전환하는데 관여하는 것으로 알려져 혈당강화에 매우 효과적인 물질로 알려져 있다(참조:대두에서 분리한 피니톨의 혈당강하효과, 한국, 식품과학과 산업, 36:1~5, 2003). 피니톨은 당뇨병의 합병증으로 나타나기 쉬운 백내장, 간 및 신장의 손상을 예방하는 효과가 있다는 것이 동물실험을 통하여 확인되고 있다. It is also known to be involved in helping blood sugar to be used as an energy source or to convert glucose into glycogen, which is known to be very effective in strengthening blood sugar. (Phytoglycemic effect of soybean isolated from soybean, Korea, Food Science and Industry, 36 : 1-5, 2003). It has been confirmed in animal studies that finitol has an effect of preventing cataract, liver and kidney damage, which are likely to be complications of diabetes.
상기와 같은 기술의 일예가 대한민국 공개특허 제2002-76095호(발명이 명칭: 대두가공 부산물로부터 카이로이노시톨 성분의 분리방법), 공개특허 제2004-35633호(발명의 명칭: 대두 유래의 카이로이노시톨의 분리 제조방법) 등이 개시되어 있다.One example of such a technique is Korean Patent Publication No. 2002-76095 (Invention name: Separation method of chiroinositol component from soybean processing by-product), Patent Publication No. 2004-35633 (Name of invention: Separation production method) and the like.
즉, 상기 공개특허공보 제2002-76095호에서는 활성탄에 흡착처리하고, 카이로이노시톨 성분, 피니톨성분, 올리고당 성분을 분획하여 회수하는 카이로이노시톨 분리방법에 대해 개시되어 있고, 상기 공개특허공보 제2004-35633호에서는 대두의 배아에 존재한 d-chiro-inosito을 얻고자 대두배아추출액을 효소반응한 후 규조토로 추출액에 존재하는 불용성 물질을 여과한 다음, 이온수지를 통과시켜 대두의 배아에서 chiro-inositol을 제조하는 방법에 대해 개시되어 있다.That is, the above-mentioned Patent Publication No. 2002-76095 discloses a method for separating chiroinositol by adsorption treatment on activated charcoal, fractionating and recovering a chiroinositol component, a finitol component, and an oligosaccharide component. In order to obtain d-chiro-inosito in soybean embryos, enzyme-reacted soybean embryo extracts were filtered, and insoluble material in the extracts was filtered with diatomaceous earth, and then chiro-inositol was prepared from soybean embryos by passing through an ionic resin. A method of doing so is disclosed.
또한, 대한민국 공개특허공보 제2004-81256호(피니톨 성분이 함유된 생식 건강보조식품의 제조방법), 공개특허공보 제2004-98839호(비수리 추출물 및 그 용도) 등에 있어서는 피니톨을 추출하고 곡류와 혼합하는 기술 또는 비수리에 물을 첨가 하고 열수추출한 후 농축 및 동결하여 추출하는 기술에 대해 개시되어 있다.In addition, Korean Patent Laid-Open Publication No. 2004-81256 (manufacturing method for reproductive health supplements containing pinitol ingredient) and Korean Patent Laid-Open Publication No. 2004-98839 (non-repair extract and its use), etc., extracts the pinitol and mixes it with cereals. A technique of adding water to non-repairing, hot water extraction, concentration and freezing and extracting is disclosed.
그러나 상기 공보 등에 기재된 기술에 있어서는 카이로이노시톨을 분리하는 방법에 대해 개시되어 있지만, 규조토 등을 매회 재생시키거나 소모되어야 하므로 제조비용이 증가하고, 그 제조공정이 복잡하다는 문제점이 있었다.However, the technique described in the above publication discloses a method for separating chiroinositol, but since diatomaceous earth and the like must be regenerated or consumed each time, there is a problem in that the manufacturing cost increases and the manufacturing process is complicated.
또, 상기 공보 제2004-81256호에 기재된 기술에 있어서는 단순히 피니톨 성분이 함유된 생식건강 보조식품에 관해 기재되어 있을 뿐 피니톨 성분을 추출하는 과정등이 구체적으로 기재되어 있지 않다는 문제점이 있었다.In addition, in the technique described in the above-mentioned publication No. 2004-81256, there is a problem that the reproductive health supplements containing the pinitol component are merely described, and the process of extracting the pinitol component is not specifically described.
본 발명의 목적은 상술한 바와 같이 종래의 문제점을 해결하기 위해 이루어진 것으로서 비수리에서 혈당조절 물질인 피니톨을 추출하고, 추출된 피니톨을 이용하여 당뇨환자에게 유용한 피니톨 추출방법 및 이 추출물을 이용한 혈당조절 기능성 식품을 제공하는 것이다An object of the present invention was made to solve the conventional problems as described above, and extracts the pinotitol, a blood sugar control substance in non-repair, and using the extracted pinitol to extract a useful pinitol and blood glucose control function using the extract To provide food
상기한 목적을 달성하기 위해 본 발명에 따른 비수리에서 피니톨을 추출하는 방법은,비수리에서 전초를 준비하는 단계, 상기 비수리를 에탄올에 첨가하고 호모게나이저로 분쇄하는 첨가분쇄단계, 분쇄된 비수리를 알콜에 정치시키는 침전단계, 침전단계에서 회수된 상등액을 원심분리하는 원심분리단계, 원심분리단계에서 회수된 상등액을 감압건조하는 감압건조단계, 감압건조단계에서 얻어진 고형분을 분리 하는 분리단계, 분리된 상등액을 이온교환수지필터를 통과 시킨 후 그 추출물을 동결건조하는 단계를 포함하는 것을 특징으로 한다.In order to achieve the above object, a method for extracting finitol in non-repair according to the present invention comprises the steps of preparing an outpost in non-repair, adding the non-repair to ethanol and grinding with a homogenizer, crushed non-repair alcohol Precipitation step to stand, centrifugation step of centrifugation of the supernatant recovered in the precipitation step, decompression drying step of drying the supernatant recovered in the centrifugation step under reduced pressure, separation step of separating the solids obtained in the vacuum drying step, separated supernatant After passing through the ion exchange resin filter is characterized in that it comprises the step of lyophilizing the extract.
본 발명의 상기 침전단계는 4℃저온실에서 약 1시간동안 정치되어 침전되는 것으로 하고, 비수리에서 피니톨을 추출하는 방법에 따라 추출된 것이다. 또한 그 추출물의 유효성분으로서는 피니톨 또는 d-chiro-inositol로 당뇨환자의 혈당을 조절함을 특징으로 한다.The precipitation step of the present invention is to be allowed to settle for about 1 hour in 4 ° C low temperature room, and is extracted according to the method of extracting finitol in non-repair. In addition, the active ingredient of the extract is characterized in that it controls the blood sugar of diabetic patients with finitol or d-chiro-inositol.
본 발명의 상기 및 그 밖의 목적과 새로운 특징은 본 명세서의 기술 및 첨부도면에 의해 더욱 명확하게 될 것이다.The above and other objects and novel features of the present invention will become more apparent from the description and the accompanying drawings.
이하, 본 발명의 실시예를 도면에 따라 구체적으로 설명한다.Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings.
<실시예1>Example 1
도 1은 본 발명에 따라 비수리에서 피니톨을 추출하는 방법을 나타낸 순서도이다.1 is a flow chart illustrating a method for extracting finitol from non-repair according to the present invention.
준비단계-단계1Preparation Steps-Step 1
신선한 비수리 전초를 1kg 준비한다.(S1)Prepare 1 kg of fresh Non-Repair Outposts.
첨가 및 분쇄단계-단계2Addition and grinding step-step 2
상기 준비된 비수리에 에탄올 70%(v/v)인 용액을 1200㎖(v)첨가하고, 지방분해를 위해 3500rpm(revolution per minute)의 호모게나이저(homogenizer)를 이용하여 20분간 분쇄한다(S2). 1200 ml (v) of a 70% (v / v) ethanol solution was added to the prepared non-repair, and pulverized for 20 minutes using a homogenizer of 3500 rpm (revolution per minute) for lipolysis (S2). .
침전단계-단계3Sedimentation Stage-Stage 3
상기 분쇄된 비수리와 에탄올이 혼합된 분쇄된 용액을 4℃ 저온실에서 약 1 시간 동안 정치시켜 침전시킨다(S3)The pulverized solution mixed with the pulverized non-repair and ethanol is allowed to settle for about 1 hour in a low temperature room at 4 ° C. (S3)
원심분리단계-단계4Centrifuge-Step 4
침전 후 위쪽에 뜨는 액체인 상등액을 새로운 용기에 옮기고, 상기 회수된 상등액에 4℃로 유지된 에탄올 60%(v/v)용액에 200㎖을 첨가하여 50㎖ 원심분리용 플래콘관(flacon tube)에 분주한 후 22000g조건에서 20분간 원심분리한다(S4).After precipitation, the supernatant liquid, which is the supernatant liquid, is transferred to a new vessel, and 200 ml of ethanol 60% (v / v) solution maintained at 4 ° C. is added to the recovered supernatant, and then 50 ml of a flacon tube for centrifugation. After dispensing in and centrifuged for 20 minutes at 22000g (S4).
감압건조단계-단계5Decompression drying step-
다시 상등액을 회수한 후 3000㎖ 감압플라스크에 옮긴 후 감압건조한다(S5).After recovering the supernatant again, transfer to a 3000ml reduced pressure flask and dried under reduced pressure (S5).
분리단계-단계6Separation Stage-
상기 단계5에서 획득된 고형분이 들어있는 감압플라스크에 3차 증류수 50㎖를 가하여 녹인 후 20㎖의 클로로포름용액을 가하여 잘 섞어준 다음 2℃ 저온실에서 12시간 동안 정치시켜 하층의 클로로포름 상등액과 추출액을 분리한다(S6).50 ml of tertiary distilled water was added to the depressurized flask containing the solid obtained in
동결건조단계-단계7Freeze drying step-step 7
상기 단계6에서 상등액을 새로운 플라스크에 옮겨 기체-액체 크로마토그래피(gas liquid chromatography)를 위한 시료로 사용하기 위하여 이온교환수지필터를 통과시킨 후 획득된 추출물을 동결건조 시킨다(S7).
이때 추출량은 건조된 비수리 전초 100g 중에서 약 0.42g정도의 피니톨이 획득된다.In
At this time, about 0.42 g of finitol is obtained from 100 g of dried non-repaired outpost.
상기에서 획득된 동결건조된 시료를 3차 증류수에 용해시킨 후 시료 1㎎에 대하여 3㎎(w/w)의 비율로 활성탄을 가하여 여과시킨 후 획득된 산물을 이용한다.The freeze-dried sample obtained above was dissolved in tertiary distilled water, and activated carbon was added at a rate of 3 mg (w / w) based on 1 mg of the sample, followed by filtration.
또 상술한 기체-액체 크로마토그래피는 Oxime-TMS 패킹의 OV-17컬럼을 이용실시 하였다.The gas-liquid chromatography described above was performed using OV-17 column of Oxime-TMS packing.
<실시예 2><Example 2>
본 실시예2에서는 본 발명에 따른 비수리 추출방법과 이 방법을 이용한 기능성식품을 이용하여 당뇨환자의 혈당조절을 위한 임상시험을 위하여 비수리를 하기와 같이 제조하였다.In Example 2, non-repair was prepared as follows for a clinical trial for glycemic control of diabetic patients using the non-repair method and the functional food using the method according to the present invention.
건조된 비수리 식물체 지상부(잎,줄기 포함) 10.5kg(W)준비한다.Prepare 10.5 kg (W) of dried non-repaired plant ground (including leaves and stems).
상기 준비된 시료는 증류수를 42ℓ(V)를 가하여 110℃ ,1.5㎏/㎤의 압력조건에서 12시간동안 열수추출하였다.
이때 추출량은 건조된 비수리 전초 100g 중에서 약 0.42g정도의 피니톨이 획득된다.42 liters (V) of distilled water was added to the prepared sample, and hot water was extracted for 12 hours under pressure conditions of 110 ° C. and 1.5 kg / cm 3.
At this time, about 0.42 g of finitol is obtained from 100 g of dried non-repaired outpost.
상기 추출된 시료를 100㎖씩 패킹장치를 이용하여 혈당 조절용 열수추출물 시료로 사용하였다.100 mL of the extracted sample was used as a sample of hot water extract for blood sugar control using a packing device.
상기과정에서 추출된 시료를 100㎖씩 패킹한 것은 실시예1의 비수리 식물체 내에 존재하는 피니톨 함량이 시료 100g(중량)당 420㎎(중량)임을 확인하고 열수추출물 시료 100㎖(V)당 100㎎(W)의 농도로 함유되도록 조정하였다.Packing 100ml each sample extracted in the above process was confirmed that the content of finitol present in the non-repairing plant of Example 1 was 420mg (weight) per 100g (weight) of the sample and 100mg per 100ml (V) of the hot water extract sample. It was adjusted to be contained at a concentration of (W).
이러한 산출근거는 420중량㎎/건조비수리 100중량g이고 성년 1일 필요한 피티놀량이 200중량㎎이므로 50중량g의 건조수리비가 필요함에 따른 것이다.The basis for this calculation is that the dry repair ratio of 420 weight mg / dry ratio repair and the weight of dry weight of 50 weight g is required because the amount of phytinol required 200 days per day of adulthood.
혈당조절을 위한 임상시험을 위하여 하기의 조사대상자에게 30일간 매일 조식과 석식 30분전에 비수리의 추출물인 피니톨이 100㎎(W) 포함된 상기의 추출물을 취식토록 한후 혈당변화를 조사하였다.For the clinical trial for glycemic control, the following subjects were examined for changes in blood glucose after eating the above extract containing 100 mg (W) of non-repaired pinitol, 30 minutes before breakfast and dinner every 30 days.
상기 표1에서는 매일 건조된 비수리 50g을 열수추출하여 30일간 조석으로 각 2회씩 식전 30분에 투여하고, 익일 조식 전 공복 시 혈당을 측정하였다.In Table 1, the dried non-repaired 50g daily was extracted with hot water and administered 30 minutes before meals 30 minutes each morning, and fasting blood glucose levels before breakfast the next day.
표1에서 알 수 있는 바와 같 본 발명은 비수리에서 추출된 피니톨이 함유된 추출물로부터 당뇨환자에게 투여개시 30일 후 약 15.4~48.4%(조사전혈당치-조사 후 혈당치=변화된 혈당수치/조사전 혈당치×100)정도로 평균 30.8%의 혈당이 개선되는 효과를 얻었다.As can be seen in Table 1, the present invention is about 15.4 ~ 48.4% (30 mg after pre-irradiation-blood glucose level after irradiation = changed blood glucose level / pre-irradiation glucose level) 30 days after the start of administration to diabetic patients from the extract containing the non-nurinate finitol X100), an average of 30.8% of blood glucose was improved.
이상 본 발명자에 의해서 이루어진 상기 실시예에 따라 구체적으로 설명하였지만 본 발명은 상기 실시예에 한정되는 것은 아니고 그 요지를 이탈하지 않는 범위에서 여러가지로 변경가능한 것은 물론이다.Although the present invention has been described in detail according to the above embodiments made by the present inventors, the present invention is not limited to the above embodiments and can be variously modified without departing from the gist of the present invention.
즉, 상기 실시예에 있어서는 비수리에서 피니톨을 추출하는 방법인 그 추출물을 취식하는 것에 대해 설명하였지만 이에 한정되는 것은 아니고, 그 밖의 생식보조식품에 첨가하여 상용할 수 있음은 물론이다.In other words, in the above embodiment, the extraction of the extract, which is a method of extracting finitol from non-repair, has been described, but the present invention is not limited thereto, and of course, it can be added to other reproductive supplements and used.
상술한 바와 같이 본 발명에 따른 피니톨 추출방법과 이 추출물을 이용한 기능성 식품에 의하면, 상기의 피니톨을 추출하는 방법에서 건조된 비수리 전초 100g 중에서 약 0.42g정도의 피니톨을 획득할 수 있었으며, 60kg정도의 체중을 가진 성인 당뇨환자에게 투여되는 성분량이 200mg(W)이상 수준이라고 볼 때, 약 40~80g(W)정도의 건조된 비수리 전초에서 당뇨환자에게 유용한 피니톨을 추출하여 혈당조절용 기능성 식품을 제공할 수 있는 효과가 얻어진다.As described above, according to the method for extracting finitol and the functional food using the extract according to the present invention, in the method for extracting the finitol, about 0.42 g of finitol was obtained from 100 g of dried non-repaired outpost, and about 60 kg of Considering that the amount of ingredient administered to adult diabetic patients with body weight is 200mg (W) or more, it is possible to provide a functional food for controlling blood sugar by extracting usefull for the diabetic patients from dried non-repaired starches of about 40 ~ 80g (W). The effect can be obtained.
또한 본 발명에 의하면 비수리는 특별히 경제작물이 경종(耕種)되지 않는 야산이나 유휴지를 이용하여 전초를 생산할 수 있으므로 토지이용을 높일 뿐만 아니라 재배하는데도 많은 비용이 들지 않으므로 경제적인 효과도 얻을 수 있다.In addition, according to the present invention, the non-nuri can produce outpost by using the mountain or idle land where economic crops are not particularly seeded. Therefore, not only the land use is increased, but also it does not cost much to cultivate.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050071952A KR100721983B1 (en) | 2005-08-05 | 2005-08-05 | Method of Extracting Finitol from Non-Repair and Functional Food Using Extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050071952A KR100721983B1 (en) | 2005-08-05 | 2005-08-05 | Method of Extracting Finitol from Non-Repair and Functional Food Using Extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070016880A KR20070016880A (en) | 2007-02-08 |
KR100721983B1 true KR100721983B1 (en) | 2007-05-28 |
Family
ID=41634534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050071952A Expired - Fee Related KR100721983B1 (en) | 2005-08-05 | 2005-08-05 | Method of Extracting Finitol from Non-Repair and Functional Food Using Extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100721983B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101080940B1 (en) | 2008-08-22 | 2011-11-08 | 김동재 | manufacture method of Lespedeza cuneata tea |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100888034B1 (en) * | 2007-02-26 | 2009-03-09 | 천윤성 | Manufacturing method of health functional drink containing non-repair and bokbunja |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040089932A (en) * | 2003-04-15 | 2004-10-22 | 주식회사 새남소재 | Moisture absorbent by a high polymer |
KR20040098839A (en) * | 2003-05-16 | 2004-11-26 | 안경민 | EXTRACTS OF Lespedeza cuneate G. Don AND THEIR USES |
KR20050031740A (en) * | 2003-09-30 | 2005-04-06 | 학교법인조선대학교 | Mixture of pine tree leaves supernatant juice fermentation solution and lespedeza cuneate g. don extract and health food containing the same |
KR20050072739A (en) * | 2005-06-21 | 2005-07-12 | 조신영 | Non-Reserved Wine |
KR100603913B1 (en) | 2001-03-27 | 2006-07-25 | 아미코젠주식회사 | Separation of Chiroinositol Components from Soybean Processing By-Products |
-
2005
- 2005-08-05 KR KR1020050071952A patent/KR100721983B1/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100603913B1 (en) | 2001-03-27 | 2006-07-25 | 아미코젠주식회사 | Separation of Chiroinositol Components from Soybean Processing By-Products |
KR20040089932A (en) * | 2003-04-15 | 2004-10-22 | 주식회사 새남소재 | Moisture absorbent by a high polymer |
KR20040098839A (en) * | 2003-05-16 | 2004-11-26 | 안경민 | EXTRACTS OF Lespedeza cuneate G. Don AND THEIR USES |
KR20050031740A (en) * | 2003-09-30 | 2005-04-06 | 학교법인조선대학교 | Mixture of pine tree leaves supernatant juice fermentation solution and lespedeza cuneate g. don extract and health food containing the same |
KR20050072739A (en) * | 2005-06-21 | 2005-07-12 | 조신영 | Non-Reserved Wine |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101080940B1 (en) | 2008-08-22 | 2011-11-08 | 김동재 | manufacture method of Lespedeza cuneata tea |
Also Published As
Publication number | Publication date |
---|---|
KR20070016880A (en) | 2007-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mbatchou et al. | Aphrodisiac activity of oils from Anacardium occidentale L seeds and seed shells | |
KR20130039309A (en) | Garlic and yolk extract including functionality food composite for health | |
MX2008012076A (en) | Extracts and methods comprising cinnamon species. | |
CN1416464A (en) | Alpha-amylase activity inhibitors | |
KR100976241B1 (en) | Extract of sedum sarmentosum for alcohol oxidation and relieves hangover | |
KR20140120667A (en) | A composition comprising the extract of Salix genus plant for treating and preventing neuro-degenerative disease | |
KR20160008425A (en) | Composition for improvement of liver function comprising exopolysaccharide derived from ceriporia lacerata culture broth extracts as an active ingredient | |
EP1640016B1 (en) | Saponin-free extracts of Asparagus Officinalis L., their preparation and their use | |
KR102264494B1 (en) | Composition for preventing, improving or treating osteoarthritis using mixture of natural ingredients | |
KR100721983B1 (en) | Method of Extracting Finitol from Non-Repair and Functional Food Using Extract | |
KR101896520B1 (en) | Hangover drink comprising desalinized magma seawater and wood extracts and process for the production thereof | |
JPH05246866A (en) | Agent for stimulating cerebral metabolism and for improving cerebral function | |
KR101731152B1 (en) | Anti-diabetic composition containing the extract of actinidia arguta leaves or fractions thereof | |
EP2420243A1 (en) | Compositions obtainable from bred beetroot juice to promote iron absorption and blood forming | |
JPH07228539A (en) | Banaba leaf extract and antidiabetic agent | |
JPH0840923A (en) | Nutrient-supplying agent | |
KR100527105B1 (en) | Pharmaceutical composition comprising the extract of Allium tuberosum ROTTER for the prevention and treatment of gout | |
KR100527109B1 (en) | Pharmaceutical composition comprising the extract of Allium tuberosum ROTTER for the prevention and treatment of gout. | |
KR100446061B1 (en) | Pharmaceutical composition and health improving food for prevention or treatment of hangover comprising microspherical crude drug powder having organic solvent adsorptive activity | |
KR102387810B1 (en) | Liquid tea containing Manuka honey, red ginseng, bilberry, and vitamins and its manufacturing method | |
KR100912290B1 (en) | Novel 6,8-di (γ, γ-dimethylallyl) -3,5,7,2 ', 4', 6'-hexahydroxyflavanone or a pharmaceutically acceptable salt thereof, preparation method thereof and effective thereof Hangover Relief Composition Containing Ingredients | |
KR20190118270A (en) | Hepatoprotective Composition Comprising Abeliophyllum Distichum Extract | |
US20210023127A1 (en) | Method to extract a pharmaceutical composition from a therapeutic compound | |
Daddala et al. | SECOISOLARICIRESINOL DIGLUCOSIDE-A POTENTIAL BIOMEDICINE OF LINUM USITATISSIMUM | |
BR102021024259A2 (en) | EXTRACTION PROCESS, ENCAPSULATION AND THERAPEUTIC APPLICATION OF BIOACTIVE COMPOUNDS FROM ABELMOSCHUS PLANTS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20050805 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20061024 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20070220 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20070518 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20070521 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20100705 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20110519 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20110519 Start annual number: 5 End annual number: 5 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |